The Bidirectional Relationship between Diabetes and Depression: A Literature Review

다국어 초록 (Multilingual Abstract)

Diabetes is a major public health problem worldwide. Depression is a serious mental condition that decreases mental and physical functioning and reduces the quality of life. Several lines of evidence suggest a bidirectional re-lationship between diabetes and depression: diabetes patients are twice as likely to experience depression than nondiabetic individuals. In contrast, depression increases the risk of diabetes and interferes with its daily self-man-agement. Diabetes patients with depression have poor glycemic control, reduced quality of life, and an increased risk of diabetes complications, consequently having an increased mortality rate. Conflicting evidence exists on the potential role of factors that may account for or modulate the relationship between diabetes and depression. There-fore, this review aims to highlight the most notable body of literature that dissects the various facets of the bidirec-tional relationship between diabetes and depression. A focused discussion of the proposed mechanisms underly-ing this relationship is also provided. We systematically reviewed the relevant literature in the PubMed database, using the keywords “Diabetes AND Depression”. After exclusion of duplicate and irrelevant material, literature eli-gible for inclusion in this review was based on meta-analysis studies, clinical trials with large sample sizes (n ≥1,000), randomized clinical trials, and comprehensive national and cross-country clinical studies. The evidence we present in this review supports the pressing need for long, outcome-oriented, randomized clinical trials to de-termine whether the identification and treatment of patients with these comorbid conditions will improve their medical outcomes and quality of life.

참고문헌 (Reference)

1 NCD Risk Factor Collaboration (NCD-RisC), "Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants" 387 : 1513-1530, 2016

2 Nouwen A, "Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis" 53 : 2480-2486, 2010

3 Vancampfort D, "Type 2 diabetes in patients with major depressive disorder: a meta-analysis of prevalence estimates and predictors" 32 : 763-773, 2015

4 Palinkas LA, "Type 2 diabetes and depressive symptoms in older adults: a population-based study" 8 : 532-539, 1991

5 Engum A, "The role of depression and anxiety in onset of diabetes in a large population-based study" 62 : 31-38, 2007

6 Anderson RJ, "The prevalence of comorbid depression in adults with diabetes: a meta-analysis" 24 : 1069-1078, 2001

7 Ali S, "The prevalence of comorbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis" 23 : 1165-1173, 2006

8 Lustman PJ, "Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial" 63 : 521-529, 2006

9 Amsterdam JD, "Safety and efficacy of s-citalopram in patients with co-morbid major depression and diabetes mellitus" 54 : 208-214, 2006

10 Osborn DP, "Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and metaanalysis" 8 : 84-, 2008

11 Lin EH, "Relationship of depression and diabetes self-care, medication adherence, and preventive care" 27 : 2154-2160, 2004

12 Yokoyama K, "Relationship between hypothalamic-pituitary-adrenal axis dysregulation and insulin resistance in elderly patients with depression" 226 : 494-498, 2015

13 Zhuang QS, "Quantitative assessment of the bidirectional relationships between diabetes and depression" 8 : 23389-23400, 2017

14 Paile-Hyvarinen M, "Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: a single-blind randomised placebo controlled trial" 4 : 7-, 2003

15 Gavard JA, "Prevalence of depression in adults with diabetes: an epidemiological evaluation" 16 : 1167-1178, 1993

16 Colle R, "Pioglitazone could induce remission in major depression: a metaanalysis" 13 : 9-16, 2016

17 Guo M, "Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus" 41 : 650-656, 2014

18 Virtanen M, "Metabolic syndrome and symptom resolution in depression: a 5-year follow-up of older adults" 78 : e1-e7, 2017

19 Lin EH, "Mental disorders among persons with diabetes: results from the World Mental Health Surveys" 65 : 571-580, 2008

20 Richardson LK, "Longitudinal effects of depression on glycemic control in veterans with type 2 diabetes" 30 : 509-514, 2008

21 Aikens JE, "Longitudinal analysis of depressive symptoms and glycemic control in type 2 diabetes" 32 : 1177-1181, 2009

22 Chen GC, "Leptin levels and risk of type 2 diabetes: gender-specific meta-analysis" 15 : 134-142, 2014

23 Chirinos DA, "Leptin and its association with somatic depressive symptoms in patients with the metabolic syndrome" 46 : 31-39, 2013

24 Jow GM, "Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia" 90 : 21-27, 2006

25 Spanakis EK, "Lack of significant association between type 2 diabetes mellitus with longitudinal change in diurnal salivary cortisol: the multiethnic study of atherosclerosis" 53 : 227-239, 2016

26 Samaan Z, "Lack of association between type 2 diabetes and major depression: epidemiologic and genetic evidence in a multiethnic population" 5 : e618-, 2015

27 Clarke TK, "Investigating shared aetiology between type 2 diabetes and major depressive disorder in a population based cohort" 174 : 227-234, 2017

28 Wang X, "Inflammatory markers and risk of type 2 diabetes: a systematic review and metaanalysis" 36 : 166-175, 2013

29 Gragnoli C, "Hypothesis of the neuroendocrine cortisol pathway gene role in the comorbidity of depression, type 2 diabetes, and metabolic syndrome" 7 : 43-53, 2014

30 Roy M, "Hypothalamic-pituitary-adrenal axis dysregulation among diabetic outpatients" 31 : 31-37, 1990

31 German J, "Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve" 150 : 4502-4511, 2009

32 Lustman PJ, "Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial" 23 : 618-623, 2000

33 Haleem DJ, "Fasting leptin and glucose in normal weight, over weight and obese men and women diabetes patients with and without clinical depression" 32 : 757-764, 2017

34 Lustman PJ, "Factors influencing glycemic control in type 2 diabetes during acute- and maintenance-phase treatment of major depressive disorder with bupropion" 30 : 459-466, 2007

35 Golden SH, "Examining a bidirectional association between depressive symptoms and diabetes" 299 : 2751-2759, 2008

36 Lustman PJ, "Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial" 59 : 241-250, 1997

37 Uchendu C, "Effectiveness of cognitive-behavioural therapy on glycaemic control and psychological outcomes in adults with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials" 34 : 328-339, 2017

38 Fisher L, "Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses" 33 : 23-28, 2010

39 Zhang X, "Depressive symptoms and mortality among persons with and without diabetes" 161 : 652-660, 2005

40 Turkington RW, "Depression masquerading as diabetic neuropathy" 243 : 1147-1150, 1980

41 Knol MJ, "Depression as a risk factor for the onset of type 2 diabetes mellitus: a meta- analysis" 49 : 837-845, 2006

42 Mezuk B, "Depression and type 2 diabetes over the lifespan: a meta-analysis" 31 : 2383-2390, 2008

43 Mendenhall E, "Depression and type 2 diabetes in low- and middle-income countries: a systematic review" 103 : 276-285, 2014

44 Schmitz N, "Depression and risk of type 2 diabetes: the potential role of metabolic factors" 21 : 1726-1732, 2016

45 Van Dooren FE, "Depression and risk of mortality in people with diabetes mellitus: a systematic review and meta-analysis" 8 : e57058-, 2013

46 Eaton WW, "Depression and risk for onset of type II diabetes: a prospective population-based study" 19 : 1097-1102, 1996

47 Lustman PJ, "Depression and poor glycemic control: a meta-analytic review of the literature" 23 : 934-942, 2000

48 Stetler C, "Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research" 73 : 114-126, 2011

49 Gonzalez JS, "Depression and diabetes treatment nonadherence: a meta-analysis" 31 : 2398-2403, 2008

50 Coleman SM, "Depression and death in diabetes; 10-year follow-up of all-cause and cause-specific mortality in a diabetic cohort" 54 : 428-436, 2013

51 Lin EH, "Depression and advanced complications of diabetes: a prospective cohort study" 33 : 264-269, 2010

52 American Psychiatric Association, "DSM-5 Task Force. Diagnostic and statistical manual of mental disorders: DSM-5" American Psychiatric Association 2013

53 Haapakoski R, "Cumulative meta-analysis of interleukins 6 and 1b, tumour necrosis factor a and C-reactive protein in patients with major depressive disorder" 49 : 206-215, 2015

54 Au B, "C-reactive protein, depressive symptoms, and risk of diabetes: results from the English Longitudinal Study of Ageing (ELSA)" 77 : 180-186, 2014

55 Herder C, "Associations between inflammation-related biomarkers and depressive symptoms in individuals with recently diagnosed type 1 and type 2 diabetes" 61 : 137-145, 2017

56 Khandaker GM, "Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study" 71 : 1121-1128, 2014

57 De Groot M, "Association of depression and diabetes complications: a meta-analysis" 63 : 619-630, 2001

58 Lopes A, "Association between major depression and type 2 diabetes mellitus: a meta-analysis and meta-regression of observational studies" 9 : 1-11, 2016

59 Palinkas LA, "A prospective study of type 2 diabetes and depressive symptoms in the elderly: the Rancho Bernardo Study" 21 : 1185-1191, 2004

60 Bruehl H, "A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitus" 34 : 815-821, 2009